This page is in verification process.
Buyers can use information for reference only. Freshdi is not responsible for information on this page.
If you own Depai Veterinary Medicine Import & Export C..., claim it to manage this profile and connect with international buyers.

China – country flag, supplier location, company info headerChina

1.1

Verification level 0

No.114 changsheng street, Shijiazhuang

Add Favorite

|

Report Supplier

|

Business Description

Depai Veterinary Medicine Import & Export Co., Ltd is a franchise veterinary medicine import and export company which is a subsidiary company of HeXin Group in China. After more than 15 years of development, HeXin Group has been covering animal health products, day-old chicks production, ducks production, feed and other fields. It has 6 subsidiary companies including Pharmaceutical Factory, Duck production Factory, Feed and Chick production Factory, and veterinary medicine import & export company which is called Depai. HeXin Group located in Luquan High-tech Development Zone of Hebei, China, has over 30, 000 square meters buildings. It has been founded an international standard GMP workshop (7450 square meters), and owned 14 production lines, which can produce 11 series: including pelvis, powder, premix, granules (including traditional Chinese medicine extraction), tablets (including traditional Chinese medicine extracts), oral solution (containing Chinese herb extracts), intravenous injection of the final mass sterilization agents, final sterilization of small volume injections (including traditional Chinese medicine extraction) the final mass sterilization of non-intravenous injection, disinfectants and pesticides, and produce over 100 medicines. Our product are saled in more than twenty provinces of China Market, and we also have exported to South Korea, Southeast Asia and Africa such as Sudan, Ethiopia and others.

Business Overview

Avg Response Time

≤ 1h

In veterinary medicine trade, products like medical injections and tablet formulations require strict quality control and regulatory compliance to be accepted by international buyers. Depai Veterinary Medicine Import & Export C... offers a range of key products used in animal health, which can appeal to buyers in regions with growing livestock industries. Being headquartered in China gives access to large-scale manufacturing and logistics networks. However, the lack of verification on phone, work email, account email, and business documents raises concerns about legitimacy and responsiveness. Buyers should request additional proof of identity and product certifications before placing large orders. Without verified contact details, it's harder to confirm real-time availability or respond to urgent inquiries. This makes due diligence essential when considering partnerships with this supplier.

Export Capabilities

Declared by supplier

Depai Veterinary Medicine Import & Export C... has been exporting since 2011.

Export start year

2011

Trade Capabilities

Business Terms

Preferred Payment Term:

Not specified

Preferred Trade Term:

Not specified

Port Of Loading:

Not specified

Accepted Currency:

USD

Trade Ability

Annual Revenue Amount:

Not specified

Numbers Of Employees:

Not specified

Avg Response Time:

-

Own this company?

Depai Veterinary Medicine Import & Export C...

China – country flag, supplier location, claim store cardChina

Unverified

Claim store, then activate and verify to showcase products.

Supplier sign-up – promo banner, free supplier page sidebar

Medical Injections market insight

Across Medical & HealthCare, the wider group Medical Injections belongs to, Freshdi lists 9 active supply listings from 9 suppliers in 6 countries, as of 17 November 2026. Medical Injections belongs to Medical & HealthCare, whose suppliers on Freshdi come from 6 countries, led by India at 22.2%, as of 17 November 2026. In the 30 days to 17 November 2026, buyer inquiries on Freshdi across Medical & HealthCare, the group Medical Injections belongs to, rose 100% against the 30 days before, with 103.41% volatility in monthly inquiry and quotation activity over 338 days.